Spots Global Cancer Trial Database for Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer
Official Title: Phase I Trial to Compare Pharmacokinetics and Safety of Docetaxel PNP With Taxotere in Subjects With Advanced Solid Tumor
Study ID: NCT02274610
Conditions
Study Description
Brief Summary: Evaluation of the pharmacokinetic equivalence of two Docetaxel formulations in terms of AUC and Cmax
Detailed Description: Comparison of pharmacokinetic parameters (T1/2β, CL, Vdss) Safety as measured by adverse events
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Mi-ryung Jin, Masters
Affiliation: Samyang Biopharmaceuticals Corporation
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
